Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 1
2006 1
2008 1
2009 4
2010 4
2011 7
2012 3
2013 5
2014 6
2015 11
2016 8
2017 6
2018 15
2019 12
2020 31
2021 24
2022 26
2023 13
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis: Extended Results of a Placebo-Controlled Phase 2 Trial.
Fox RJ, Wiendl H, Wolf C, De Stefano N, Sellner J, Gryb V, Rejdak K, Bozhinov PS, Vitt D, Kohlhof H, Slizgi J, Ondrus M, Sciacca V, Muehler AR; EMPhASIS investigators. Fox RJ, et al. Among authors: rejdak k. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200208. doi: 10.1212/NXI.0000000000200208. Epub 2024 Apr 25. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38662979 Free article. Clinical Trial.
Expert opinion of the Heart Rhythm Association of the Polish Cardiac Society and the Polish Neurological Society on evidence-driven implementation of implantable loop recorders in Poland.
Karliński MA, Grabowski M, Kempa M, Farkowski MM, Sławek J, Rejdak K, Mitkowski P, Hryniewiecki T, Słowik A. Karliński MA, et al. Among authors: rejdak k. Kardiol Pol. 2024;82(3):353-359. doi: 10.33963/v.phj.99401. Epub 2024 Mar 17. Kardiol Pol. 2024. PMID: 38493471 Free article.
Analysis of seroconversion following COVID-19 vaccination among multiple sclerosis patients treated with disease-modifying therapies in Poland.
Podlecka-Piętowska A, Sierdziński J, Nojszewska M, Stawicki J, Bartosik-Psujek H, Lech B, Popiel M, Perenc A, Kułakowska A, Czarnowska A, Kulikowska J, Kapica-Topczewska K, Jamróz-Wiśniewska A, Rejdak K, Zaborski J, Kubicka-Bączyk K, Niedziela N, Wierzbicki K, Adamczyk-Sowa M, Zwiernik J, Zwiernik B, Milewska-Jędrzejczak M, Głąbiński A, Jasińska E, Puz P, Krzystanek E, Stęposz A, Karuga A, Lasek-Bal A, Siuda J, Kściuk B, Walawska-Hrycek A, Patalong-Ogiewa M, Kaczmarczyk A, Siutka K, Brola W, Zakrzewska-Pniewska B. Podlecka-Piętowska A, et al. Among authors: rejdak k. Neurol Neurochir Pol. 2024;58(1):112-119. doi: 10.5603/pjnns.96425. Epub 2024 Jan 22. Neurol Neurochir Pol. 2024. PMID: 38251955 Free article.
The use of andexanet alpha in the Polish setting: An interdisciplinary protocol. Expert consensus statement of the Polish Cardiac Society.
Kazimierczyk E, Dąbrowska M, Gierlotka M, Kapica-Topczewska K, Karaszewski B, Kobayashi A, Krasiński Z, Kubica J, Kułakowska A, Kurek K, Ładny R, Pleban E, Rejdak K, Rydzewska G, Słowik A, Szopiński P, Woźniak A, Tycińska A. Kazimierczyk E, et al. Among authors: rejdak k. Kardiol Pol. 2024;82(1):123-139. doi: 10.33963/v.kp.98059. Epub 2024 Jan 17. Kardiol Pol. 2024. PMID: 38230495 Free article.
External quality monitoring facilitates improvement in already well-performing stroke units: insights from RES-Q Poland.
Karliński M, Kobayashi A, Niewada M, Fryze W, Tomczak A, Brola W, Rejdak K, Luchowski P, Adamkiewicz B, Wiszniewska M, Włodarczyk U, Kaźmierski R, Kram P, Bartosik-Psujek H, Kaczorowski R, Sobolewski P, Fudala M, Gałązka A, Rogoziewicz M, Rogoziewicz A, Sienkiewicz-Jarosz H, Cybulska E, Pożarowszczyk N, Staszewski J, Dębiec A, Horoch-Łyszczarek E, Mączkowiak A, Czlonkowska A. Karliński M, et al. Among authors: rejdak k. Neurol Neurochir Pol. 2024;58(1):75-83. doi: 10.5603/pjnns.96442. Epub 2023 Dec 1. Neurol Neurochir Pol. 2024. PMID: 38037889 Free article.
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group. Bateman RJ, et al. N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430. N Engl J Med. 2023. PMID: 37966285 Clinical Trial.
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.
Fissolo N, Benkert P, Sastre-Garriga J, Mongay-Ochoa N, Vilaseca-Jolonch A, Llufriu S, Blanco Y, Hegen H, Berek K, Perez-Miralles F, Rejdak K, Villar LM, Monreal E, Alvarez-Lafuente R, Soylu OK, Abdelhak A, Bachhuber F, Tumani H, Martínez-Yélamos S, Sánchez-López AJ, García-Merino A, Gutiérrez L, Castillo-Trivino T, Lycke J, Rosenstein I, Furlan R, Filippi M, Téllez N, Ramió-Torrentà L, Lünemann JD, Wiendl H, Eichau S, Khalil M, Kuhle J, Montalban X, Comabella M. Fissolo N, et al. Among authors: rejdak k. J Neurol Neurosurg Psychiatry. 2024 Apr 12;95(5):410-418. doi: 10.1136/jnnp-2023-332251. J Neurol Neurosurg Psychiatry. 2024. PMID: 37940409
168 results